About Us

PT Widya Teknologi Hayati: Pioneering Indonesia’s Path to Biotechnological Sovereignty

PT Widya Teknologi Hayati (Widya Life Science) is a biotechnological research company dedicated to advancing the exploration and production of bioactive compounds in Indonesia. We envision a future where the nation achieves complete bioindependence by producing essential biotechnological tools locally, empowering researchers, and fostering sustainable innovation.

At the heart of our mission lies a simple yet profound realization: to accelerate research progress, Indonesia must reduce its reliance on imported reagents and consumables. Our commitment to bioindependence stems from the belief that local production of molecular tools is essential for national sovereignty in biotechnology. By leveraging Indonesia’s rich plant and microbial biodiversity, we aim to create a robust foundation for green biotechnology research and development.

Widya Life Science is structured into two key divisions, each playing a critical role in realizing this vision. The Plant & Microbial Biotechnology Research Division is home to three specialized research laboratories focusing on fungal, bacterial, and plant biotechnology. These laboratories are equipped with cutting-edge facilities to support advanced research activities, including plant and microbial micropropagation, plant tissue culture, molecular biology analysis (DNA, RNA, and protein), genomic research, genetic engineering, and biotechnological innovations involving plants and microbes.

The Biological Production Development Division is focused on scaling biotechnological solutions for industrial applications. This division encompasses a pilot-scale production facility for plant tissue culture and microbial products, and Indonesia’s first oligo production line, launched in October 2024. This facility represents a significant milestone in reducing dependency on imported DNA primers and other molecular tools, supporting research in molecular biology and diagnostics.

The journey toward bioindependence began with a stark realization: Indonesia’s reliance on imported molecular tools hindered scientific progress and exposed the nation to global supply chain vulnerabilities. To address this challenge, Widya Life Science, in collaboration with the Biotechnology Study Center at Universitas Gadjah Mada (UGM) and Yayasan Satriabudi Dharma Setia (YSDS), established a bold plan to develop local production capabilities. This vision has been realized through the successful launch of the oligo production line, with plans to expand into enzyme production and nucleotide triphosphate (NTP) synthesis in the future.

We are Indonesian biotechnologists who made the simple realization that to accelerate research progress, we need to stop waiting for imported reagents and consumables. We are determined to start the long journey towards bio-independence and sovereignty, helping Indonesian scientists work faster and better – advancing humanity with biotechnology.